Clarus Therapeutics Holdings, Inc. SC 13D and SC 13D/A reports

Location
355 S. Grand Avenue, Suite 1450, Los Angeles, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
7/19/2024, 08:53 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report SC 13D/A Apr 22, 2022
SC 13D Report SC 13D Dec 10, 2021
SC 13D Report SCHEDULE 13D Sep 21, 2021